Azerbaijan vs Iceland: Cause of death, by non-communicable diseases, ages 5-14, female
Azerbaijan
33.2%
in 2021
Iceland
33.3%
in 2021
Azerbaijan rank
118th
Iceland rank
116th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Azerbaijan
- Iceland
How they compare
Iceland currently reports 33.3% against 33.2% in Azerbaijan, a difference of 0.1%.
Across all 6 years both countries report, Iceland has been ahead every year.
Azerbaijan ranks 118th and Iceland ranks 116th of 184 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.9% | 33.3% | 6.4% | Iceland |
| 2010s | 34.1% | 71.9% | 37.8% | Iceland |
| 2020s | 25.2% | 32.8% | 7.7% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Azerbaijan or Iceland?
- Iceland, at 33.3% against 33.2% in Azerbaijan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Azerbaijan and Iceland?
- 0.1%, with Iceland ahead.
- How many years of comparable data are there for Azerbaijan and Iceland?
- 6 years are reported by both, from 2000 to 2021.
- How do Azerbaijan and Iceland rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Azerbaijan ranks 118th and Iceland ranks 116th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.